Powell, M A · Journal of the American Academy of Nurse Practitioners · 1990 · DOI
This study looked at whether people with ME/CFS have higher levels of antibodies against Epstein-Barr virus (a common virus that causes mononucleosis) compared to healthy people. Researchers measured these antibody levels in patients diagnosed with chronic fatigue syndrome to see if there was a connection between past or ongoing EBV infection and the development of ME/CFS.
Understanding potential links between viral infections like EBV and ME/CFS onset is crucial for patients seeking explanations for their illness and for researchers investigating disease mechanisms. This early work contributed to ongoing investigations into whether viral reactivation or persistent infection plays a role in ME/CFS development.
This study does not establish that EBV causes ME/CFS, nor does it prove that EBV reactivation is necessary or sufficient for disease development. Observational findings cannot determine causation, and without comparison to control populations, we cannot conclude whether EBV antibody levels in ME/CFS patients differ meaningfully from the general population.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →